- Issuer ticker
-
OCX
- Reported as of
-
13 Jan 2025
- Net transaction value
-
+$34,114
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
15 Jan 2025, 17:00:16 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Patrick W. Smith
Key filing fact
Patrick W. Smith filed Form 4 for Oncocyte Corp (OCX) on 15 Jan 2025.
Key facts
- This page summarizes Patrick W. Smith's Form 4 filing for Oncocyte Corp (OCX).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jan 2025, 17:00.
Change
- Previous filing in this sequence was filed on 27 Dec 2024.
- Current net transaction value: +$34,114.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCX
transaction
Common Stock, no par value
Purchase
- Transaction value
- $11,792
- Shares
- +5,669
- Change %
- +0.32%
- Price
-
$2.08
- Shares after
- 1,779,572
- Date
- 13 Jan 2025
- Ownership
- See footnote
- Footnotes
- F1
OCX
transaction
Common Stock, no par value
Purchase
- Transaction value
- $208
- Shares
- +100
- Change %
- +0.01%
- Price
-
$2.08
- Shares after
- 1,779,672
- Date
- 14 Jan 2025
- Ownership
- See footnote
- Footnotes
- F1
OCX
transaction
Common Stock, no par value
Purchase
- Transaction value
- $22,115
- Shares
- +10,286
- Change %
- +0.58%
- Price
-
$2.15
- Shares after
- 1,789,958
- Date
- 14 Jan 2025
- Ownership
- See footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote